Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Abiraterone Acetate +5 More for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
New Haven, Connecticut
This trial is testing the safety and effectiveness of a new drug, AZD4635, for treating patients with advanced solid tumors. The maximum tolerated dose will be determined in patients and expansion cohorts will assess safety and preliminary anti-tumor activity.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.